Patents

Locus Pharmaceuticals wins drug-design patents

Published in AIDS Weekly, March 8th, 2004

Sarnoff Corp., the Princeton, New Jersey-based innovation services and technology development company, praised the announcement from Locus Pharmaceuticals of Blue Bell, Pennsylvania, that the U.S. Patent and Trademark Office has allowed the claims of a patent application for computerized drug-design technology originally developed by Sarnoff.

The technology was exclusively licensed to Locus for use in developing new therapies for various disease states including AIDS, cancer, and rheumatoid arthritis.

The technology was developed by Dr. Frank Guarnieri, principal founding scientist of Locus, while he was at Sarnoff. Locus Pharmaceuticals was founded...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2004-03-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry